Deficiencies in our present protocol for chemical evaluation and possible remedies.
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001681:Biological Assay; D002273:Carcinogens / Q000494:pharmacology; D003582:Cytogenetics; D064420:Drug-Related Side Effects and Adverse Reactions; D005069:Evaluation Studies as Topic; D005799:Genes, Dominant; D005804:Genes, Lethal; D005823:Genetics; D009153:Mutagens / Q000494:pharmacology; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D014116:Toxicology; D014481:United States; D014486:United States Food and Drug Administration
D002273:Carcinogens; D009153:Mutagens; D004364:Pharmaceutical Preparations